Agilent Technologies Inc. and SomaLogic, Inc. Enter Agreement to Expand Access to Cutting-Edge Proteomic Technology

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SANTA CLARA, Calif. & BOULDER, Colo.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) and SomaLogic Inc. (a privately held biotechnology company) announced today that they have entered into an agreement to expand access to SomaLogic’s unbiased protein biomarker discovery platform.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC